Risk of multiple myeloma is associated with polymorphisms within telomerase genes and telomere length

Daniele Campa, Alessandro Martino, J. Várkonyi, Fabienne Lesueur, Krzysztof Jamroziak, Stefano Landi, Artur Jurczyszyn, Herlander Marques, Vibeke Andersen, Manuel Jurado, Hermann Brenner, Mario Petrini, Ulla Vogel, Ramón García-Sanz, Gabriele Buda, Federica Gemignani, Rafael Ríos, Annette Juul Vangsted, Charles Dumontet, Joaquín Martínez-López & 16 others María José Moreno, Anna Sterpień, Marzena Wątek, Victor Moreno, Aida Karina Dieffenbach, Anna Maria Rossi, Katja Butterbach, Svend E Hove Jacobsen, Hartmut Goldschmidt, Juan Sainz, Jens Hillengass, Enrico Orciuolo, Marek Dudziński, Niels Weinhold, Rui Manuel Reis, Federico Canzian

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Compelling biological and epidemiological evidences point to a key role of genetic variants of the TERT and TERC genes in cancer development. We analyzed the genetic variability of these two gene regions using samples of 2,267 multiple myeloma (MM) cases and 2,796 healthy controls. We found that a TERT variant, rs2242652, is associated with reduced MM susceptibility (OR=0.81; 95% CI: 0.72-0.92; p=0.001). In addition we measured the leukocyte telomere length (LTL) in a subgroup of 140 cases who were chemotherapy-free at the time of blood donation and 468 controls, and found that MM patients had longer telomeres compared to controls (OR=1.19; 95% CI: 0.63-2.24; ptrend=0.01 comparing the quartile with the longest LTL versus the shortest LTL). Our data suggest the hypothesis of decreased disease risk by genetic variants that reduce the efficiency of the telomerase complex. This reduced efficiency leads to shorter telomere ends, which in turn may also be a marker of decreased MM risk.

Original languageEnglish
Pages (from-to)E351-E358
JournalInternational Journal of Cancer
Volume136
Issue number5
DOIs
Publication statusPublished - Mar 1 2015

Fingerprint

Telomerase
Telomere
Multiple Myeloma
Leukocytes
Genes
Inborn Genetic Diseases
Neoplasm Genes
Blood Donors
Drug Therapy

Keywords

  • Multiple myeloma
  • Polymorphisms
  • Susceptibility
  • Telomerase
  • Telomere length

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Medicine(all)

Cite this

Risk of multiple myeloma is associated with polymorphisms within telomerase genes and telomere length. / Campa, Daniele; Martino, Alessandro; Várkonyi, J.; Lesueur, Fabienne; Jamroziak, Krzysztof; Landi, Stefano; Jurczyszyn, Artur; Marques, Herlander; Andersen, Vibeke; Jurado, Manuel; Brenner, Hermann; Petrini, Mario; Vogel, Ulla; García-Sanz, Ramón; Buda, Gabriele; Gemignani, Federica; Ríos, Rafael; Vangsted, Annette Juul; Dumontet, Charles; Martínez-López, Joaquín; Moreno, María José; Sterpień, Anna; Wątek, Marzena; Moreno, Victor; Dieffenbach, Aida Karina; Rossi, Anna Maria; Butterbach, Katja; Jacobsen, Svend E Hove; Goldschmidt, Hartmut; Sainz, Juan; Hillengass, Jens; Orciuolo, Enrico; Dudziński, Marek; Weinhold, Niels; Reis, Rui Manuel; Canzian, Federico.

In: International Journal of Cancer, Vol. 136, No. 5, 01.03.2015, p. E351-E358.

Research output: Contribution to journalArticle

Campa, D, Martino, A, Várkonyi, J, Lesueur, F, Jamroziak, K, Landi, S, Jurczyszyn, A, Marques, H, Andersen, V, Jurado, M, Brenner, H, Petrini, M, Vogel, U, García-Sanz, R, Buda, G, Gemignani, F, Ríos, R, Vangsted, AJ, Dumontet, C, Martínez-López, J, Moreno, MJ, Sterpień, A, Wątek, M, Moreno, V, Dieffenbach, AK, Rossi, AM, Butterbach, K, Jacobsen, SEH, Goldschmidt, H, Sainz, J, Hillengass, J, Orciuolo, E, Dudziński, M, Weinhold, N, Reis, RM & Canzian, F 2015, 'Risk of multiple myeloma is associated with polymorphisms within telomerase genes and telomere length', International Journal of Cancer, vol. 136, no. 5, pp. E351-E358. https://doi.org/10.1002/ijc.29101
Campa, Daniele ; Martino, Alessandro ; Várkonyi, J. ; Lesueur, Fabienne ; Jamroziak, Krzysztof ; Landi, Stefano ; Jurczyszyn, Artur ; Marques, Herlander ; Andersen, Vibeke ; Jurado, Manuel ; Brenner, Hermann ; Petrini, Mario ; Vogel, Ulla ; García-Sanz, Ramón ; Buda, Gabriele ; Gemignani, Federica ; Ríos, Rafael ; Vangsted, Annette Juul ; Dumontet, Charles ; Martínez-López, Joaquín ; Moreno, María José ; Sterpień, Anna ; Wątek, Marzena ; Moreno, Victor ; Dieffenbach, Aida Karina ; Rossi, Anna Maria ; Butterbach, Katja ; Jacobsen, Svend E Hove ; Goldschmidt, Hartmut ; Sainz, Juan ; Hillengass, Jens ; Orciuolo, Enrico ; Dudziński, Marek ; Weinhold, Niels ; Reis, Rui Manuel ; Canzian, Federico. / Risk of multiple myeloma is associated with polymorphisms within telomerase genes and telomere length. In: International Journal of Cancer. 2015 ; Vol. 136, No. 5. pp. E351-E358.
@article{e1f5186f8fdb46eea4ad6daf1545f4bf,
title = "Risk of multiple myeloma is associated with polymorphisms within telomerase genes and telomere length",
abstract = "Compelling biological and epidemiological evidences point to a key role of genetic variants of the TERT and TERC genes in cancer development. We analyzed the genetic variability of these two gene regions using samples of 2,267 multiple myeloma (MM) cases and 2,796 healthy controls. We found that a TERT variant, rs2242652, is associated with reduced MM susceptibility (OR=0.81; 95{\%} CI: 0.72-0.92; p=0.001). In addition we measured the leukocyte telomere length (LTL) in a subgroup of 140 cases who were chemotherapy-free at the time of blood donation and 468 controls, and found that MM patients had longer telomeres compared to controls (OR=1.19; 95{\%} CI: 0.63-2.24; ptrend=0.01 comparing the quartile with the longest LTL versus the shortest LTL). Our data suggest the hypothesis of decreased disease risk by genetic variants that reduce the efficiency of the telomerase complex. This reduced efficiency leads to shorter telomere ends, which in turn may also be a marker of decreased MM risk.",
keywords = "Multiple myeloma, Polymorphisms, Susceptibility, Telomerase, Telomere length",
author = "Daniele Campa and Alessandro Martino and J. V{\'a}rkonyi and Fabienne Lesueur and Krzysztof Jamroziak and Stefano Landi and Artur Jurczyszyn and Herlander Marques and Vibeke Andersen and Manuel Jurado and Hermann Brenner and Mario Petrini and Ulla Vogel and Ram{\'o}n Garc{\'i}a-Sanz and Gabriele Buda and Federica Gemignani and Rafael R{\'i}os and Vangsted, {Annette Juul} and Charles Dumontet and Joaqu{\'i}n Mart{\'i}nez-L{\'o}pez and Moreno, {Mar{\'i}a Jos{\'e}} and Anna Sterpień and Marzena Wątek and Victor Moreno and Dieffenbach, {Aida Karina} and Rossi, {Anna Maria} and Katja Butterbach and Jacobsen, {Svend E Hove} and Hartmut Goldschmidt and Juan Sainz and Jens Hillengass and Enrico Orciuolo and Marek Dudziński and Niels Weinhold and Reis, {Rui Manuel} and Federico Canzian",
year = "2015",
month = "3",
day = "1",
doi = "10.1002/ijc.29101",
language = "English",
volume = "136",
pages = "E351--E358",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "5",

}

TY - JOUR

T1 - Risk of multiple myeloma is associated with polymorphisms within telomerase genes and telomere length

AU - Campa, Daniele

AU - Martino, Alessandro

AU - Várkonyi, J.

AU - Lesueur, Fabienne

AU - Jamroziak, Krzysztof

AU - Landi, Stefano

AU - Jurczyszyn, Artur

AU - Marques, Herlander

AU - Andersen, Vibeke

AU - Jurado, Manuel

AU - Brenner, Hermann

AU - Petrini, Mario

AU - Vogel, Ulla

AU - García-Sanz, Ramón

AU - Buda, Gabriele

AU - Gemignani, Federica

AU - Ríos, Rafael

AU - Vangsted, Annette Juul

AU - Dumontet, Charles

AU - Martínez-López, Joaquín

AU - Moreno, María José

AU - Sterpień, Anna

AU - Wątek, Marzena

AU - Moreno, Victor

AU - Dieffenbach, Aida Karina

AU - Rossi, Anna Maria

AU - Butterbach, Katja

AU - Jacobsen, Svend E Hove

AU - Goldschmidt, Hartmut

AU - Sainz, Juan

AU - Hillengass, Jens

AU - Orciuolo, Enrico

AU - Dudziński, Marek

AU - Weinhold, Niels

AU - Reis, Rui Manuel

AU - Canzian, Federico

PY - 2015/3/1

Y1 - 2015/3/1

N2 - Compelling biological and epidemiological evidences point to a key role of genetic variants of the TERT and TERC genes in cancer development. We analyzed the genetic variability of these two gene regions using samples of 2,267 multiple myeloma (MM) cases and 2,796 healthy controls. We found that a TERT variant, rs2242652, is associated with reduced MM susceptibility (OR=0.81; 95% CI: 0.72-0.92; p=0.001). In addition we measured the leukocyte telomere length (LTL) in a subgroup of 140 cases who were chemotherapy-free at the time of blood donation and 468 controls, and found that MM patients had longer telomeres compared to controls (OR=1.19; 95% CI: 0.63-2.24; ptrend=0.01 comparing the quartile with the longest LTL versus the shortest LTL). Our data suggest the hypothesis of decreased disease risk by genetic variants that reduce the efficiency of the telomerase complex. This reduced efficiency leads to shorter telomere ends, which in turn may also be a marker of decreased MM risk.

AB - Compelling biological and epidemiological evidences point to a key role of genetic variants of the TERT and TERC genes in cancer development. We analyzed the genetic variability of these two gene regions using samples of 2,267 multiple myeloma (MM) cases and 2,796 healthy controls. We found that a TERT variant, rs2242652, is associated with reduced MM susceptibility (OR=0.81; 95% CI: 0.72-0.92; p=0.001). In addition we measured the leukocyte telomere length (LTL) in a subgroup of 140 cases who were chemotherapy-free at the time of blood donation and 468 controls, and found that MM patients had longer telomeres compared to controls (OR=1.19; 95% CI: 0.63-2.24; ptrend=0.01 comparing the quartile with the longest LTL versus the shortest LTL). Our data suggest the hypothesis of decreased disease risk by genetic variants that reduce the efficiency of the telomerase complex. This reduced efficiency leads to shorter telomere ends, which in turn may also be a marker of decreased MM risk.

KW - Multiple myeloma

KW - Polymorphisms

KW - Susceptibility

KW - Telomerase

KW - Telomere length

UR - http://www.scopus.com/inward/record.url?scp=84918779782&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84918779782&partnerID=8YFLogxK

U2 - 10.1002/ijc.29101

DO - 10.1002/ijc.29101

M3 - Article

VL - 136

SP - E351-E358

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 5

ER -